VP, Pharmacology & Toxicology
Tony Muchamuel serves as Vice President, Toxicology and Pharmacology at Kezar Life Sciences, and has led nonclinical drug development efforts in immunology and oncology since 2016. Tony has performed research in the biopharmaceutical industry for more than 20 years including at Amgen, Onyx Pharmaceuticals, Proteolix, Corgentech Inc., and DNAX Research Institute. He has authored/coauthored 22 scientific publications and 8 US patent applications.
Tony attended San Francisco State University where he received his Bachelor of Science degree in Physiology and Master of Science degree in Clinical Science.